Results 91 to 100 of about 44,168 (193)

Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer

open access: yesCells
Argininosuccinate synthetase 1 (ASS1) expression and arginine availability are key metabolic determinants that influence tumor fitness and regulate immune interactions within the tumor microenvironment (TME).
Hila Tishler   +28 more
doaj   +1 more source

Suggested guidelines for the diagnosis and management of urea cycle disorders

open access: yesOrphanet Journal of Rare Diseases, 2012
Urea cycle disorders (UCDs) are inborn errors of ammonia detoxification/arginine synthesis due to defects affecting the catalysts of the Krebs-Henseleit cycle (five core enzymes, one activating enzyme and one mitochondrial ornithine/citrulline antiporter)
Häberle Johannes   +14 more
doaj   +1 more source

Integration of metabolite and transcript data of ornithine-linked pathways.

open access: yes, 2019
The squares indicate changes on both transcription and metabolic level in response to a CO2-shift from 400 ppm to 100 ppm (Student´s t-test ...
Miriam Laxa (6236678)   +4 more
core   +1 more source

Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene

open access: yes, 2008
Citrullinemia type I is an autosomal recessive disorder that is caused by a deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS1). Deficiency of ASS1 shows various clinical manifestations encompassing severely affected patients with ...
Engel, K   +5 more
core   +1 more source

Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma

open access: yesiScience
Summary: Pleural mesothelioma is a highly chemotherapy-resistant cancer. Approximately 50% of mesotheliomas do not express argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme in arginine biosynthesis, making arginine depletion with pegylated ...
Josephine Carpentier   +6 more
doaj   +1 more source

Model of reciprocal regulation of arginase 1 (ARG1) and nitric oxide synthase 2 (NOS2).

open access: yes, 2015
Downstream metabolic products (blue framed) and their association with components of inflammatory responses (red). Enzymes (blue ellipses), NOHA: N-hydroxyarginine, OAT: ornithine aminotransferase, ODC: ornithine decarboxylase, ACL: argininosuccinate ...
Frieder Hadlich (732945)   +3 more
core   +1 more source

Insights into the dynamic cell associated and secreted proteome of Staphylococcus aureus cultured in TSB and milk media: a proteomic analysis

open access: yesBMC Microbiology
The availability of nutrients is closely linked to the protein expression profile of microorganisms. In this study, a comparative investigation has been performed to examine the expression patterns of cell associated proteins and secreted proteins in ...
Wanting Zhu   +9 more
doaj   +1 more source

Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease.

open access: yes, 2001
peer reviewedThe enzyme argininosuccinate synthetase (ASS) is the rate limiting enzyme in the metabolic pathway leading from L-citrulline to L-arginine, the physiological substrate of all isoforms of nitric oxide synthases (NOS).
Feinstein, Douglas L.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy